Diabetes treatment is constantly progressing, with new therapeutic options developing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the actions of naturally occurring hormones involved in bloodlevel regulation. These novel agents demonstrate significant efficacy in

The management of diabetes is with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant attention. These medications offer promising mechanisms for controlling blood sugar levels and potentially improve the lives of individuals living with diabetes. Reta| acts by